Relationship between Body Mass Index and Clinical Manifestation of Polyendocrine Metabolic Ovarian Syndrome: A Cross-Sectional Study
Naogaon Medical College Journal · 2026
DOI: 10.70818/nmcj.v03i01.036 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Naogaon Medical College Journal, 2026. Verfasst von Most Kamrunnahar und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polyendocrine metabolic ovarian syndrome shapes reproductive, dermatological, and metabolic health, yet its BMI-stratified expression remains poorly characterized in South Asian district-hospital populations.
Objective
This study evaluated whether BMI-defined weight categories predict the clinical manifestations of polyendocrine metabolic ovarian syndrome among reproductive-age women.
Methods
A cross-sectional observational study enrolled 112 women aged 18–65 years diagnosed under Rotterdam consensus criteria at the Department of Gynaecology and Obstetrics, 250-Bedded General Hospital, Jhenaidah, between January 2024 and June 2025. Patients were stratified using WHO Asian-Pacific BMI cut-offs; clinical, dermatological, and biochemical variables were compared across categories using chi-square and one-way ANOVA in SPSS v26.0.
Results
Mean BMI was 26.5±4.6 kg/m² (range 14.9–38.5); 43.8% (n=49) were obese, 35.7% (n=40) overweight, 16.1% (n=18) normal-weight, and 4.5% (n=5) underweight. Acanthosis nigricans prevalence rose from 20.0% in normal-weight to 67.5% in overweight and 46.9% in obese patients (χ²=6.80, p=0.078). Hirsutism prevalence ranged from 55.6–65.3% across strata (p=0.768); mean Ferriman–Gallwey scores ranged from 8.5–9.8 (p=0.701). HOMA-IR (2.74–3.11), fasting glucose (5.60–6.32 mmol/L), and waist–hip ratio (0.849–0.872) did not differ significantly across categories (all p>0.05). BMI correlated weakly and non-significantly with HOMA-IR (r=−0.071, p=0.456) and fasting glucose (r=−0.111, p=0.244). Complication incidence was 5.36% (6/112).
Conclusion
Clinical manifestations of polyendocrine metabolic ovarian syndrome were highly prevalent but distributed similarly across BMI strata, indicating that phenotypic severity in South Asian women cannot be inferred from adiposity alone
Zitieren
APA
Kamrunnahar, M., Alam, M. S., Islam, S., Naznin, F., & Yeasmin, M. D. (2026). Relationship between Body Mass Index and Clinical Manifestation of Polyendocrine Metabolic Ovarian Syndrome: A Cross-Sectional Study. Naogaon Medical College Journal. https://doi.org/10.70818/nmcj.v03i01.036
Vancouver
Kamrunnahar M, Alam MS, Islam S, Naznin F, Yeasmin MD. Relationship between Body Mass Index and Clinical Manifestation of Polyendocrine Metabolic Ovarian Syndrome: A Cross-Sectional Study. Naogaon Medical College Journal. 2026. doi:10.70818/nmcj.v03i01.036
BibTeX
@article{Kamrunnahar2026,
author = {Kamrunnahar, Most and Alam, Md Shah and Islam, Samina and Naznin, Farhana and Yeasmin, Mst Dilruba},
title = {Relationship between Body Mass Index and Clinical Manifestation of Polyendocrine Metabolic Ovarian Syndrome: A Cross-Sectional Study},
journal = {Naogaon Medical College Journal},
year = {2026},
doi = {10.70818/nmcj.v03i01.036}
}
EUVIMED